Egis ups guidance
Hungarian drugmaker Egis, majority-owned by France's Servier, has raised its projection for forint-term revenue growth in the business year started October 1 to 3-5%, CFO Csaba Poroszlai said at a press conference on Thursday, a day after the company published its Q2 report.
After publishing its Q1 report in February, Egis projected revenue would edge up 0-2% in the 2011/12 business year.
Poroszlai said Egis lowered its target for growth on the CIS market to 5-10% from 10-12% because of a big drop in stocks that may not be replenished by year-end. He added that the Russian drug market was growing at a slower than expected pace.
Egis sees sales in Eastern Europe falling 10-15%, at a faster rate than the 5% drop projected earlier.
Egis is standing by its earlier projection for revenue growth of 0-5% on other markets.
Poroszlai said Russia had become Egis's biggest market at the end of the Q2, while domestic revenue slipped to just 25% of the total. He added that the proportion could fall under 20% in the coming years.
He said that blind auctions started under a new subsidy system launched in Hungary last year had caused prices to fall and forced Egis to withdraw three product -- all earlier winners of an innovation prize -- from the domestic market in the first half. He added that the blind auction system was expected to cause Egis's revenue to fall by HUF 1 billion every half year.
Egis's net profit climbed 42.2% to HUF 6.45 billion in Q2 from the same period a year earlier, rising on an improved margin and a slight financial gain, the company said in its consolidated IFRS report published late Tuesday.
Revenue rose 6.1% to HUF 33.5 billion. Costs of sales rose at a slower rate, increasing 4.6% to HUF 13.9 billion. Gross profit was up 7.2% at HUF 19.6 billion.
Egis booked a HUF 101 million net financial gain in Q1, compared to a HUF 1.27 billion loss in the base period.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.